Patents by Inventor Jerry L. Adams

Jerry L. Adams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyridin-4-YL or pyrimidin-4-YL substituted pyrazines
    Patent number: 6861417
    Abstract: Novel pyridin-4-yl or pyrimidin-4-yl substituted pyrazine compounds and compositions for use in therapy.
    Type: Grant
    Filed: April 14, 2003
    Date of Patent: March 1, 2005
    Assignee: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Ralph F. Hall, Jeffrey C. Boehm
  • Substituted imidazole compounds
    Patent number: 6858617
    Abstract: Novel 1,4,5-substituted imidazole compounds and compositions for use in therapy as ERK/MAP inhibitors of ERK/MAP mediated diseases.
    Type: Grant
    Filed: June 2, 2003
    Date of Patent: February 22, 2005
    Assignee: SmithKline Beecham Corporation
    Inventor: Jerry L. Adams
  • Novel compounds
    Publication number: 20040209901
    Abstract: Novel substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Application
    Filed: April 6, 2004
    Publication date: October 21, 2004
    Applicant: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Jeffrey C. Boehm, Ralph Hall, Qi Jin, Jiri Kasparec, Domingos J. Silva, John J. Taggart
  • Pyrazole and pyrazoline substituted compounds
    Patent number: 6774127
    Abstract: Novel pyridyl and pyrimidinyl substituted pyrazole and pyrazoline compounds and compositions for use in therapy.
    Type: Grant
    Filed: February 19, 2003
    Date of Patent: August 10, 2004
    Assignee: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Timothy Gallagher, Irennegbe Kelly Osifo
  • 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
    Patent number: 6759410
    Abstract: The present invention relates to 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolines of formula (1), or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: July 6, 2004
    Assignee: SmithLine Beecham Corporation
    Inventors: Jerry L. Adams, Michael J. Bower, Ralph Hall, Don Edgar Griswold, David C. Underwood
  • Novel compounds
    Publication number: 20040116697
    Abstract: Novel substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Application
    Filed: April 18, 2003
    Publication date: June 17, 2004
    Inventors: Jerry L. Adams, Jeffrey C. Boehm, Ralph Hall, Qi Jin, Jiri Kasparec, Domingos J. Silva, John J. Taggart
  • Novel compounds
    Publication number: 20040053943
    Abstract: The present invention is directed to novel compounds of Formula (I) for use in the treatment of diseases in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred.
    Type: Application
    Filed: May 20, 2003
    Publication date: March 18, 2004
    Inventors: Jerry L. Adams, Deborah L. Bryan
  • Pyridin-4-YL or pyrimidin-4-YL substituted pyrazines
    Publication number: 20040014973
    Abstract: Novel pyridin-4-yl or pyrimidin-4-yl substituted pyrazine compounds and compositions for use in therapy.
    Type: Application
    Filed: April 14, 2003
    Publication date: January 22, 2004
    Applicant: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Ralph F. Hall, Jeffrey C. Boehm
  • Novel substituted imidazole compounds
    Publication number: 20040002509
    Abstract: Novel 1,4,5-substituted imidazole compounds and compositions for use in therapy as ERK/MAP inhibitors of ERK/MAP mediated diseases.
    Type: Application
    Filed: June 2, 2003
    Publication date: January 1, 2004
    Applicant: SmithKline Beecham Corporation
    Inventor: Jerry L. Adams
  • Novel substituted triazole compounds
    Publication number: 20030229110
    Abstract: Novel substituted triazole compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Application
    Filed: March 26, 2003
    Publication date: December 11, 2003
    Applicant: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Dennis Lee
  • Aryloxy substituted pyrimidine imidazole compounds
    Patent number: 6610695
    Abstract: Novel 2,4,5-triaryl substituted imidazole compounds and compositions for use in therapy of CSBP/RK/p38 mediated diseases.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: August 26, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Dennis Lee, Scott A. Long
  • Novel pyrazole and pyrazoline substituted compounds
    Publication number: 20030153569
    Abstract: Novel pyridyl and pyrimidinyl substituted pyrazole and pyrazoline compounds and compositions for use in therapy.
    Type: Application
    Filed: February 19, 2003
    Publication date: August 14, 2003
    Applicant: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Timothy Gallagher, Irennegbe Kelly Osifo
  • Substituted triazole compounds
    Patent number: 6599910
    Abstract: Novel substitued triazole compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Grant
    Filed: June 11, 2001
    Date of Patent: July 29, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Dennis Lee
  • Novel substituted imidazole compounds
    Publication number: 20030114452
    Abstract: Novel 1,4,5-substituted imidazole compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Application
    Filed: May 17, 2002
    Publication date: June 19, 2003
    Applicant: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Ralph F. Hall
  • 1,5- disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
    Publication number: 20030100756
    Abstract: Novel substituted pyrimido[4,5-d]pyrimidin-2-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Application
    Filed: August 28, 2002
    Publication date: May 29, 2003
    Inventors: Jerry L Adams, Jeffrey C Boehm, John J Taggart, Ralph F Hall
  • Substituted imidazole compounds
    Patent number: 6569871
    Abstract: Novel 1,4,5 substituted imidazole compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Grant
    Filed: December 15, 1999
    Date of Patent: May 27, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Jerry L Adams, Ralph F Hall
  • Substituted imidazole compounds
    Patent number: 6562832
    Abstract: Novel 1,4,5-subsituted imidazole compounds and compositions for use in therapy as cytokine inhibitors.
    Type: Grant
    Filed: December 15, 1999
    Date of Patent: May 13, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Jeffrey C. Boehm, Timothy Francis Gallagher
  • Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
    Patent number: 6548503
    Abstract: The present invention is directed to novel pyridin-4-yl or pyrimidin-4-yl substituted pyrazine compounds and compositions for use in therapy.
    Type: Grant
    Filed: April 5, 2001
    Date of Patent: April 15, 2003
    Assignee: Smithkline Beecham Corporation
    Inventors: Jerry L. Adams, Ralph F. Hall, Jeffrey C. Boehm
  • Substituted imidazoles having anti-cancer and cytokine inhibitory activity
    Patent number: 6548520
    Abstract: The present invention is related to novel 2-alkyl substituted imidazoles of formula (I) useful for the treatment of CSBP kinase mediated diseases.
    Type: Grant
    Filed: March 3, 2001
    Date of Patent: April 15, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Susan B. Dillon, Sandra D. Griego, Dennis Lee
  • Novel substituted imidazole compounds
    Publication number: 20030069243
    Abstract: Novel 1,4,5 substituted imidazole compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Application
    Filed: July 19, 2002
    Publication date: April 10, 2003
    Applicant: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Ralph F. Hall